Concord Drugs fundamental analysis
CONCORD
83
0.21 (-0.25%)Last updated on 20 Nov, 2025 | 11:20 IST
BUYSELL
The current prices are delayed, login to your account for live prices
LoginConcord Drugs Fundamentals
P/E Ratio
144.46
P/B Ratio
2.42
Div. Yield
0
Sector P/E
37.59
Sector P/B
3.65
Sec. Div. Yield
0.57
- Concord Drugs Fundamentals is currently trading with a P/E Ratio of 144.46, compared to the sector average of 37.59. Its P/B Ratio stands at 2.42, while the sector’s is 3.65. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 0.57%.
Concord Drugs Score Card
Price
Attractive
Growth
Poor
Quality
Poor
Management
Poor
- On its scorecard, Concord Drugs reflects: Price – Attractive, Growth – Poor, Quality – Poor, and Management – Poor. Together, these indicators provide a structured view of the company’s fundamentals.